{"title":"Developing self-aware mindfulness to manage mood disorder in the adolescent - A Case Report","authors":"K. Puspitasari","doi":"10.35990/amhs.v1n1.p45-53","DOIUrl":null,"url":null,"abstract":"Major depressive disorder (MDD) with psychotic is a complicated affective disease\ncharacterized by abnormal clinical sympotms, including neurovegetative disfunction (appetite\nor sleep disturbances), cognitive dissonance (inappropriate guilt, feelings of worthlessness),\naberrant psychomotor activities (agitation or retardation), and elevated suicide risk with\npsychotic features such as delusions or nihilistic, non-bizarre delusions, somatic, poverty,\nworthlessness, or delusional beliefs about guilt and being punished, and sometimes appear\nhallucination. The prevalence of MDD with psychotic features increases with age. In general\npopulation, the point prevalence of MDD is about 2% to 4% and it is increasing about 20%\nlifetime risk. Depression is a leading cause of burden of disease among young people. Current\ntreatments are not uniformly effective, in part due to the heterogeneous nature of MDD. MDD\nis caused by many factors. A 22-year-old male presented to the inpatient psychiatric unit with\nsuicide attempt. The patient reported experiencing a lack of energy, difficulty falling asleep,\nlack of motivation, and feeling overwhelmed about his work and experiencing auditoric\nhallucination. The insight level was 5. Multiaxial diagnosis are axis I: major depressive episode\nwith psychotic symptoms; axis II and III: currently not found; axis IV: problems with\nworkplace; axis V: GAF 20-11. Patient treated with pharmacotherapy group Selective\nSerotonin Reuptake Inhibitor (SSRI) and second-generation antipsychotics which combined\nwith supportive psychotherapy such as mindfullness.","PeriodicalId":171840,"journal":{"name":"ACTA Medical Health Sciences","volume":"35 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACTA Medical Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.35990/amhs.v1n1.p45-53","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
Major depressive disorder (MDD) with psychotic is a complicated affective disease
characterized by abnormal clinical sympotms, including neurovegetative disfunction (appetite
or sleep disturbances), cognitive dissonance (inappropriate guilt, feelings of worthlessness),
aberrant psychomotor activities (agitation or retardation), and elevated suicide risk with
psychotic features such as delusions or nihilistic, non-bizarre delusions, somatic, poverty,
worthlessness, or delusional beliefs about guilt and being punished, and sometimes appear
hallucination. The prevalence of MDD with psychotic features increases with age. In general
population, the point prevalence of MDD is about 2% to 4% and it is increasing about 20%
lifetime risk. Depression is a leading cause of burden of disease among young people. Current
treatments are not uniformly effective, in part due to the heterogeneous nature of MDD. MDD
is caused by many factors. A 22-year-old male presented to the inpatient psychiatric unit with
suicide attempt. The patient reported experiencing a lack of energy, difficulty falling asleep,
lack of motivation, and feeling overwhelmed about his work and experiencing auditoric
hallucination. The insight level was 5. Multiaxial diagnosis are axis I: major depressive episode
with psychotic symptoms; axis II and III: currently not found; axis IV: problems with
workplace; axis V: GAF 20-11. Patient treated with pharmacotherapy group Selective
Serotonin Reuptake Inhibitor (SSRI) and second-generation antipsychotics which combined
with supportive psychotherapy such as mindfullness.
伴精神病的重度抑郁症(MDD)是一种复杂的情感性疾病,其特征是异常的临床症状,包括神经植物功能障碍(食欲或睡眠障碍)、认知失调(不适当的内疚、无价值感)、异常的精神运动活动(躁动或发育迟缓),以及伴有精神病性特征的自杀风险升高,如妄想或虚无主义、非奇异妄想、躯体、贫困、无价值、抑郁和抑郁。或者是关于内疚和受到惩罚的妄想,有时是幻觉。伴有精神病性特征的重度抑郁症的患病率随着年龄的增长而增加。在一般人群中,重度抑郁症的点患病率约为2%至4%,其终生风险增加约20%。抑郁症是造成年轻人疾病负担的主要原因。目前的治疗方法并不一致有效,部分原因是由于重度抑郁症的异质性。mddi是由多种因素引起的。一名22岁男性因企图自杀被送往精神科住院。患者报告说,他感到精力不足,难以入睡,缺乏动力,对自己的工作感到不知所措,并出现了幻听。洞察水平是5级。多轴诊断为I轴:伴精神病性症状的重度抑郁发作;轴二和轴三:目前未找到;轴四:工作场所的问题;轴V: GAF 20-11。患者采用药物治疗组选择性血清素再摄取抑制剂(SSRI)和第二代抗精神病药物联合正念等支持性心理治疗。